[1]
V. K. Sehgal, T. Vashisht, G. Singh, and N. Sharma, “A Pharmacoeconomic Analysis to Determine the Relative Cost-effectiveness of Timolol 0.5%, Brinzolamide 1% and Brimonidine 0.2% Eye Drops in Treatment of Primary Open Angle Glaucoma/Ocular Hypertension”, IJMDS, pp. 1766–1774, Jul. 2019.